• DOI:10.1111/jdv.13752
Corpus ID: 1228654

Glucagonoma syndrome: a review and update on treatment

@article{John2016GlucagonomaSA,
  title={Glucagonoma syndrome: a review and update on treatment},
  author={A. John and R. Schwartz},
  journal={Journal of the European Academy of Dermatology and Venereology},
  year={2016},
  volume={30}
}

A. John, R. Schwartz

Published 2016

Medicine

Journal of the European Academy of Dermatology and Venereology

Glucagonoma syndrome is defined by the presence of an alpha‐cell secreting tumour of the pancreas, elevated levels of glucagon, and a characteristic rash called necrolytic migratory erythema (NME). NME is usually a specific and often initial finding of glucagonoma syndrome, but it may occur in other settings unassociated with an alpha‐cell pancreatic tumour (pseudoglucagonoma syndrome). Glucagonoma syndrome must be distinguished from pseudoglucagonoma syndrome. Prompt recognition of NME and… CONTINUE READING

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed